Clinical Trial

Self-Efficacy and Medication Adherence in Patients With Coronary Artery Disease: A Descriptive Study

Study acronym: SEMACAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This descriptive study aims to examine the relationship between self-efficacy and medication adherence in individuals with coronary artery disease (CAD). The study will be conducted between March and October 2025 at Adıyaman University Training and Research Hospital with a planned sample size of 135 participants. Data will be collected using a Descriptive Information Form, the Self-Efficacy for Managing Chronic Disease Scale, and the Medication Adherence Report Scale (MARS).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-17.
Trial Details
NCT Number NCT06943157
Lead Sponsor Hasan Kalyoncu University
Conditions Coronary Artery Disease
Enrollment 135 participants
Start Date 2025-03-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-27